Neuroinflammation and immune-brain interactions

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

358 papers

Showing 157-168 of total 358 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

TREM1/DAP12-mediated neuron-microglia crosstalk in ischemic stroke: Huangxiong formula reduces Neuroinflammation and neuronal Pyroptosis.

Zhang P; Xia W; Huang Y; Yu J; Huang Y; Wang N

2026PubMedDirectly related

Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease.

Abdel-Rasol MA

Jan 1, 2026Inflammopharmacology

2026PubMedDirectly related

ELAVL3 Exacerbates Brain Injury and Cognitive Dysfunction in Mice After Cardiac Arrest by Increasing S100B mRNA Stability to Promote Microglia Activation.

Ji X; Xia Y; Zhao Y; Wu Y; Zhang P

Jan 1, 2026Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

2026PubMedSupporting evidence

AI-guided discovery of a brain-penetrant LILRB4 inhibitor active in microglial and 5xFAD models of Alzheimer's disease.

Abdel-Rahman SA; Gabr MT

Jan 1, 2026Bioorganic chemistry

2026PubMedDirectly related

TRANQUIL attenuates autoimmune demyelination and suppresses neuroinflammatory signaling in experimental autoimmune encephalomyelitis.

Xu S; Ai W; Liu Z; Sun Y; Song BS; Xiong X; Adams LG; de Figueiredo P; Song J

Jan 1, 2026Brain research

2026PubMedSupporting evidence

Network pharmacological combined with in vivo and in vitro validation reveals the mechanisms of atrazine-induced Parkinson's disease-related neurotoxicity.

Liu Y; Wang L; Xiang G; Huang Y; Wang J; Cai Q

Jan 1, 2026Toxicology and applied pharmacology

2026PubMedSupporting evidence

Estrogen relieved chronic pain-triggered cognitive dysfunction via restraining excessive inhibition in PV interneurons related to neuroinflammation.

Tan X; Chen Y; Dai H; Gao Y; Ang Y; Yao J; Qiu L; Wang J; Sun J

Jan 1, 2026Neurochemistry international

2026PubMedDirectly related

Hematoma-driven immuno-epigenetic remodeling after intracerebral hemorrhage: cell-type-specific mechanisms and therapeutic opportunities.

Li Y; Jiang W; Zhong F; Dong M

Jan 1, 2026Frontiers in immunology

2026PubMedSupporting evidence

Neuroinflammation-associated thalamocortical functional connectivity and cognition in older adults.

Browndyke J; Reekes T; Wright MC; Smith MR; Devinney M; Boykin P; Upadhya VR; Zhu D; Martucci KT; Shaw LM; Waligorska T; Herber C; Tian Yu C; Zetterberg H; Blennow K; Huebner JL; Cohen HJ; Whitson H; Mathew JP; Berger M; INTUIT & MADCO-PC Trial Investigators

Jan 1, 2026Journal of neuroinflammation

2026PubMedSupporting evidence

Circadian Rhythm Disruption in Alzheimer's Disease: Mechanistic Insights, Diagnostic Implications, and Emerging Chronotherapeutic Strategies: A Narrative Review.

Kaur J; Kainth R; Mittal R; Kaur A; Kushwah AS

Jan 1, 2026CNS & neurological disorders drug targets

2026PubMedDirectly related

The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer's Disease Pathogenesis and Therapeutics.

Fatima J; Siddique YH

Jan 1, 2026CNS & neurological disorders drug targets

2026PubMedDirectly related

Short-Chain Fatty Acids and FFAR2: Modulators of the Gut-Brain Axis in Neuroinflammatory Disorders.

Kaur H; Das J; Sah AK; Bhui U; Tursunbaevna KF; Khan N; Akter B; Sharma J; Khurana N; Kumar B; Sharma N

Jan 1, 2026Current pharmaceutical design